GSK

  • GSK faces Q4 profit wipe-out on $3 billion legal hit 18-01-2011 06:05 PM

    London: GlaxoSmithKline will record a legal charge of 2.2 billion pounds ($3.4 billion) for the fourth quarter, effectively wiping out its profit, as it settles further claims related to Avandia and sales practices. The charge equates to an after-tax cost of 1.8 billion pounds, more than the 1.45 billion the...